NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹2,291 Cr | ₹1,674 Cr | ₹862 Cr | ₹202 Cr | ₹580 Cr |
What is the latest Profit Before Tax of NATCO PHARMA ?
| Year | Profit Before Tax |
|---|---|
| Mar2026 | ₹2,291 Cr |
| Mar2025 | ₹1,674 Cr |
| Mar2024 | ₹862 Cr |
| Mar2023 | ₹202 Cr |
| Mar2022 | ₹580 Cr |
How is Profit Before Tax of NATCO PHARMA Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,291 Cr | 36.92 | |
| Mar2025 | ₹1,674 Cr | 94.16 | |
| Mar2024 | ₹862 Cr | 326.26 | |
| Mar2023 | ₹202 Cr | -65.11 | |
| Mar2022 | ₹580 Cr | - | |
Compare Profit Before Tax of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,018.4 Cr | -1.3% | -8.6% | -4.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,826.0 Cr | -1.6% | -2.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,019.0 Cr | 1.5% | 12.8% | 48.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,875.0 Cr | -0.9% | -0.8% | 35.3% | Stock Analytics | |
| CIPLA | ₹112,773.0 Cr | -1.6% | -5.2% | -11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,570.9 Cr | -2.2% | -2.3% | -8.2% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -1.3% |
-8.6% |
-4.2% |
| SENSEX | -1.1% |
-3.6% |
-5.3% |
You may also like the below Video Courses